Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF MARCH 17, 2002 FBO #0105
SOURCES SOUGHT

A -- Folate and Neural Tube Defects

Notice Date
3/15/2002
 
Notice Type
Sources Sought
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, National Institute of Child Health and Human Development, Contracts Management Branch 6100 Executive Blvd., Suite 7A07, MSC7510, Bethesda, MD, 20892-7510
 
ZIP Code
20892-7510
 
Solicitation Number
Reference-Number-NICHD-SS-DESPR-04
 
Response Due
4/29/2002
 
Archive Date
5/14/2002
 
Point of Contact
Charles Grewe, Lead Contract Specialist, Phone 301-435-6957, Fax 301-402-3676,
 
E-Mail Address
cg59b@nih.gov
 
Description
FOLATE and NEURAL TUBE DEFECTS The National Institute of Child Health and Human Development is planning to extend the period of performance of its contract with The Health Research Board (HRB) of Dublin,Ireland for a clinical research study entitled, "Folate and Neural Tube Defects". The HRB received award N01-HD-2-3163 to participate in an NICHD study to demonstrate how folate supplements reduce the occurrence of neural tube defects in a high risk population. The HRB has developed a unique, geographically-based study of women who have had blood samples collected during pregnancies that produced infants with neural tube defects. The proposed extension will expand on previously conducted biochemical and genetic investigations and continue recruitment. Extensive biochemical analysis has been performed on study subjects. Continuity requires that the same laboratory perform biochemical testing for the future work. This is particularly important in the case of folate assays which have been shown by a CDC study to produce results that vary substantially from laboratory to laboratory. Any organization that has: 1. a geographically-based sample of women who are not using vitamin supplements on whom blood has been collected during pregnancies resulting in neural tube defect offspring, 2. blood samples from subjects with neural tube defects and first degree relatives, 3. genetic data from a genetically homogeneous population relevant to neural tube defects for families with neural tube defect members, and 4. the capability of conducting other genetic investigations and is interested in performing these tasks, should submit a statement of capabilities with documentation supporting its ability to meet the Government's requirements to continue this project. The purpose of this synopsis is to determine whether there are other sources with the requisite qualifications to perform the work as described. This is not a request for proposals. Capability statements, not to exceed 20 pages, should be submitted within 45 days of the publication of this synopsis to: Mr. Charles W. Grewe, Contracting Officer, CMB, OAM, NICHD, NIH, 6100 Executive Boulevard, Room 7A07,MSC 7510, Bethesda, Maryland 20892-7510 or via e-mail at cg59b@nih.gov.(See Numbered Note 22).
 
Place of Performance
Address: Health Research Board, 73 Lower Baggot Street, Dublin 2
Country: Ireland
 
Record
SN00043379-W 20020317/020315213151 (fbodaily.com)
 
Source
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  © 1994-2020, Loren Data Corp.